Hydroxychloroquine sulfate prophylaxis for pulmonary embolism for patients with low-friction arthroplasty.
Hydroxycholoroquine sulfate has been administered for prophylaxis against pulmonary embolism following total hip arthroplasty. A significant reduction was observed in the rate of fatal emboli, with relatively few and minor side effects, on daily doses of 1200 mg.
D003911:Dextrans / Q000627:therapeutic use; D006622:Hip Prosthesis; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000517:prevention & control*; D014945:Wound Healing
D003911:Dextrans; D006886:Hydroxychloroquine